1. In-Depth Characterization of Live Vaccines Used in Europe for Oral Rabies Vaccination of Wildlife.
- Author
-
Cliquet F, Picard-Meyer E, Mojzis M, Dirbakova Z, Muizniece Z, Jaceviciene I, Mutinelli F, Matulova M, Frolichova J, Rychlik I, and Celer V
- Subjects
- Animals, Europe, Genetic Variation, Genome, Viral, High-Throughput Nucleotide Sequencing, RNA, Viral, Rabies Vaccines genetics, Rabies virus genetics, Vaccination veterinary, Animal Diseases prevention & control, Animals, Wild, Rabies veterinary, Rabies Vaccines immunology, Rabies virus immunology, Vaccines, Attenuated
- Abstract
Although rabies incidence has fallen sharply over the past decades in Europe, the disease is still present in Eastern Europe. Oral rabies immunization of wild animal rabies has been shown to be the most effective method for the control and elimination of rabies. All rabies vaccines used in Europe are modified live virus vaccines based on the Street Alabama Dufferin (SAD) strain isolated from a naturally-infected dog in 1935. Because of the potential safety risk of a live virus which could revert to virulence, the genetic composition of three commercial attenuated live rabies vaccines was investigated in two independent laboratories using next genome sequencing. This study is the first one reporting on the diversity of variants in oral rabies vaccines as well as the presence of a mix of at least two different variants in all tested batches. The results demonstrate the need for vaccine producers to use new robust methodologies in the context of their routine vaccine quality controls prior to market release.
- Published
- 2015
- Full Text
- View/download PDF